Active — Not RecruitingNot Applicable

Clinical Observation of Renal Function Reactivation Following a GRAS-Based Protocol in Patients With Chronic Kidney Disease and Long-Term Renal Arrest.

Algeria8 participantsStarted 2026-02-02

Plain-language summary

This observational study documents the impact of a specific oral protocol (based on FDA-GRAS ingredients) on patients with Stage 5 Chronic Kidney Disease (CKD). The study observes 8 participants, including 6 with residual renal function and 2 patients with long-term total renal arrest (16 years and 22 years of anuria). The primary focus is monitoring the restoration of urine output and changes in renal biological markers.

Who can participate

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Sampling Method: Non-Probability Sample Criteria: Patients with confirmed Stage 5 CKD on or off dialysis, with documented periods of renal inactivity ranging from residual function to 20+ years of total arrest.ion Criteria: * Aged 18 and older" et "Diagnosed with ESRD (End-Stage Renal Disease)". Exclusion Criteria: * Pregnant women

What they're measuring

Change in Daily Urine Output Volume

Timeframe: Baseline and every month for to 6 months

Trial details

NCT IDNCT07555327

SponsorAmar h Zireg

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-04-15

View on ClinicalTrials.gov More End-Stage Renal Disease (ESRD) Chronic Kidney Disease, Stage 5 Renal Regeneration Anuria Diabetic Nephropathy trials